This paper is in the following e-collection/theme issue:

Formative Evaluation of Non-Ehealth Innovations (156) Registered Report (668) HIV/AIDS/STI Prevention and Care (941) Posttraumatic Stress Disorder (PTSD) (124) Medication Adherence (117) Anxiety and Stress Disorders (1174) Theoretical Frameworks and Concepts (294) Patient Engagement and Empowerment (50)

Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64258, first published .
Assessment, Decision, Adaptation, Production, Topical Experts-Integration, Training, and Testing (ADAPT-ITT) Framework to Tailor Evidence-Based Posttraumatic Stress Disorder Treatment for People With HIV to Enhance Engagement and Adherence: Qualitative Results from a Feasibility Randomized Controlled Trial

Assessment, Decision, Adaptation, Production, Topical Experts-Integration, Training, and Testing (ADAPT-ITT) Framework to Tailor Evidence-Based Posttraumatic Stress Disorder Treatment for People With HIV to Enhance Engagement and Adherence: Qualitative Results from a Feasibility Randomized Controlled Trial

Assessment, Decision, Adaptation, Production, Topical Experts-Integration, Training, and Testing (ADAPT-ITT) Framework to Tailor Evidence-Based Posttraumatic Stress Disorder Treatment for People With HIV to Enhance Engagement and Adherence: Qualitative Results from a Feasibility Randomized Controlled Trial

Authors of this article:

Cristina M Lopez1 Author Orcid Image ;   Angela D Moreland1 Author Orcid Image ;   Stephanie Amaya1 Author Orcid Image ;   Erin Bisca1 Author Orcid Image ;   Christin Mujica2 Author Orcid Image ;   Tayler Wilson1 Author Orcid Image ;   Nathaniel Baker3 Author Orcid Image ;   Lauren Richey4 Author Orcid Image ;   Allison Ross Eckard5 Author Orcid Image ;   Patricia A Resick6 Author Orcid Image ;   Steven A Safren7 Author Orcid Image ;   Carla Kmett Danielson1 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.